NCT00828282
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
8,990 public trials
1,836 recruiting studies
Lymphatic Diseases trial results
NCT00290472
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Burkitt Lymphoma, +54 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States
- Evanston Hospital CCOP Evanston, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States
Completed
Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
NCT00058019
- Conditions
- Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +25 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT00132028
- Conditions
- Adult Favorable Prognosis Hodgkin Lymphoma, Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, +14 more
- Locations
-
- Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States
NCT00184041
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
NCT01280526
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Hôpital Henri Mondor Créteil, France
- CHU de Dijon Dijon, France
- Hôpital Claude Huriez Lille, France
- Centre Léon Bérard Lyon, France
NCT00184080
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
Completed
Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
NCT00098670
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States
NCT00121199
- Conditions
- Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- SWOG Portland, Oregon, United States
NCT01358253
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China